Delivery Order SPE2DR25D3103-SPE2DR26F9L58
- Not listed
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pens with a ceiling value of $2,684.16. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,848.69 delivery order to AmerisourceBergen Drug Corp on December 7, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 8, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,752.08 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 9, 2025, and represents a child order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,776.41 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $18,854.38 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units) with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,208.75 on November 12, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens (0.5 mL). This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by November 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within the company's...
- The Defense Logistics Agency awarded a $10,019.57 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens (0.5 ml units). This competitively awarded, firm fixed-price contract will be completed by July 21, 2025, with performance taking place at the vendor's Corporate Office in Conshohocken, Pennsylvania. The award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $28,019.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pens on August 6, 2025, with completion scheduled for August 7, 2025. The delivery will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9L58Delivery Order
The Defense Logistics Agency awarded a $8,690.90 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle, leveraging the company's established relationship with the federal medical supply chain. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime pharmaceutical supply vehicle enables AmerisourceBergen to deliver a comprehensive range of medications and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The Mounjaro order fulfills federal medical procurement needs for diabetes treatment as part of the company's extensive pharmaceutical distribution portfolio supporting the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 12/2/25 |